Ruti Aga's Six Years: The Ban Was Written on Paper, Not in Blood

The document that pushed Ruti Aga six years off the track was not a laboratory report. It was a prescription pad. The pad is said to have come from a former workplace, and that clinic has flatly denied ever issuing it. The person who wrote the prescription is a family member with no medical registration attached to her name. The substance was methylprednisolone, a glucocorticoid used to control inflammation and prohibited in-competition. Yet the six years in this case were written in the paper ledger, not in the blood sample.

The sanction runs from 10 September. She is 32. Add six years and the return lands near 38, at the far edge of the marathon's age curve, where only a handful of athletes still race and none of them carries a forcibly inserted six-year hole in the middle of a career.

Aga won the 2026 Tokyo Marathon. According to the sanction notice and the competition record, she also owns three runner-up finishes at World Marathon Majors. Inside the Ethiopian high-altitude marathon pipeline that profile reads as stable, bankable podium class — an athlete races are not built around, but results are incomplete without. That is precisely where this case acquires its structure.

The competition where the sample was collected was a half marathon she won in China in March. The announcement gives no race name, no winning time, no course, and no sample type, urine or blood. I am not counting those gaps for sport. Positioning a mark against an athlete's own career requires all four. With what is missing I will not pretend to prove anything; I will only say that the notice leaves no route to place that March performance against her 2026-19 peak.

I was hired to draw the first shot map, and I treated every dot like a vow. Through Russia 2026 my remote desk became a vigil of time zones and touch maps; here the vigil was dates, missing fields, and a quiet note written beside every absence. I do not ask the data to speak; I command it into a decision. The decision here is plain: what happened in the paperwork, not what happened on the road, is the centre of this file.

Read her competitive tier and the architecture of the case becomes visible. One Major win plus three Major runner-up finishes places her in the global top 15 to 25 of her generation. Not dominant, but permanently on the step behind dominance, where income is driven by appearance fees and podium bonuses rather than global endorsements. That tier races the second and third strata of road racing most often, where the testing footprint is set not by the race's commercial profile but by the local national anti-doping organisation and targeted Athletics Integrity Unit work. High fee, low surveillance: the classic exposure zone for a mid-tier elite.

What matters pharmacologically is timing, not dosage. Methylprednisolone reduces inflammation, exactly the drug class a marathoner with a complaining knee is given. Under the WADA framework glucocorticoids are prohibited in-competition only, and only by injectable, oral or rectal routes. A properly documented out-of-competition injection with clearance is entirely defensible. A detectable in-competition presence is not. Her knee explanation may well be true, and she is still liable, because timing converted therapy into a violation.

The arithmetic inside the six years is less comfortable still. As the notice is structured, the bulk of the sanction derives from the tampering charge, with the underlying violation added on top. No prior sanction appears in the announcement, so repeat-offender escalation is not the driver. In marathon terms: she received six years largely for a forged document. A fake prescription has drawn more time than plenty of genuine performance-enhancing cases, and that uncomfortable ordering is a problem inside the anti-doping code itself, and the least discussed part of this file.

The mark that now matters is not a time but a deletion. The March half marathon result will be disqualified with everything attached: title, prize money, ranking points. The 2026 Tokyo title survives this decision untouched. But the annulled result was the only visible evidence of her current form, and erasing it leaves the archive with no recent indicator at all. That is the archive's job: to keep the account of what gets deleted.

When I rebuilt a burned library after the pandemic emptied the calendar, I set one rule: hand-timed and electronically timed marks are never compared naively. The road-racing equivalent is course profile, altitude, women-only versus mixed fields, and shoe generation. Her 2026-19 peak sits inside the first-generation carbon-plate dividend, so the eight-to-nine-minute gap between her best and the current world-record tier cannot be decomposed into shoe, training and course without course-level data. I will not pretend to decompose it.

The age curve is unforgiving. The marathon's extended peak runs roughly 27 to 33, with outliers past 35. Returning at 38 and reaching Major level is improbable rather than impossible, because six years out means more than missing races: it means missing the elite training group, the agent-managed calendar and the testing system. In the Addis Ababa, Sululta and Asella belt, six years outside is six years off the pipeline. And because her income model rests on fees and podium bonuses, the financial damage is close to total rather than marginal.

The real crisis in this case is entourage, not doping. A marathoner with an injury needs a licensed team physician who understands therapeutic use exemptions. Instead we have a family member with no registration, an old pad, and a clinic's denial. That can be personal foolishness; structurally it is the shadow medical channel that runs through agents and families in high-altitude camps and keeps no document trail. The sanction landed on one athlete. The channel is intact.

The case also has to be read against itself. A real knee, a real injection and a forged document are three separate facts. Strict liability does not require proof of intent, so the clinic's denial does not establish that she knew the pad was fake, and her knowledge does not change the sanction's arithmetic either. Concluding from this file that Ethiopian athletics is dirty, or that the system worked, is a leap in both directions. The system caught a bad document, not a programme. And if the document is the bulk of the six years, the fair question is whether anti-doping now measures cleanliness or measures paperwork discipline.

Sports culture worships memory; I audit the memory with timestamps. In this audit Aga's career splits in two: a 2026 Tokyo that stands, and a March half marathon that has been erased. Between them sits a six-year hole inside which nobody will ever know how good she actually was. Watch three things next: whether an appeal reaches the Court of Arbitration for Sport, where the prize-money clawback from the annulled result lands, and whether anti-doping bodies close the family-member-as-doctor loophole. And keep one question open: if the annulled result was her only recent data point, did we punish the athlete or delete the evidence?